Viral infection in community-acquired pneumonia: A systematic review and meta-analysis

European Respiratory Review

Volumn 25, Issue 140, 2016, Pages 178-188

  Burk, Michael ^a   El Kersh, Karim ^a   Saad, Mohamed ^a   Wiemken, Timothy ^a   Ramirez, Julio ^a   Cavallazzi, Rodrigo ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CORONAVIRIDAE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA VIRUS; META ANALYSIS; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT EXAMINATION; REVIEW; RHINOVIRUS; SENSITIVITY ANALYSIS; SEROLOGY; SYSTEMATIC REVIEW; VIRUS CULTURE; VIRUS INFECTION; ADULT; AGED; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GENETICS; MALE; MIDDLE AGED; NASOPHARYNX; ODDS RATIO; OROPHARYNX; PATHOGENICITY; PNEUMONIA, VIRAL; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; VIROLOGY; VIRUS;

VIRUS DNA;

ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNX; ODDS RATIO; OROPHARYNX; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VIRUSES;

EID: 84971500544     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0076-2015     Document Type: Review

References (50)

1. Templeton KE, Scheltinga SA, van den Eeden WC, et al. Improved diagnosis of the etiologyof community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005; 41: 345-351.
2. Choi SH, Hong SB, Ko GB, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012; 186: 325-332.
3. Angeles Marcos M, Camps M, Pumarola T, et al. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther 2006; 11: 351-359.
4. Cao B, Ren LL, Zhao F, et al. Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. Eur J Clin Microbiol Infect Dis 2010; 29: 1443-1448.
5. van Gageldonk-Lafeber AB, Wever PC, van der Lubben IM, et al. The aetiology of community-acquired pneumonia and implications for patient management. Neth J Med 2013; 71: 418-425.
6. Hara K, Yahara K, Gotoh K, et al. Clinical study concerning the relationship between community-acquired pneumonia and viral infection in northern Thailand. Intern Med 2011; 50: 991-998.
7. Mermond S, Berlioz-Arthaud A, Estivals M, et al. Aetiology of community-acquired pneumonia in hospitalized adult patients in New Caledonia. Trop Med Int Health 2010; 15: 1517-1524.
8. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008; 63: 42-48.
9. Luchsinger V, Ruiz M, Zunino E, et al. Community-acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax 2013; 68: 1000-1006.
10. Takahashi K, Suzuki M, Minh le N, et al. The incidence and aetiology of hospitalised community-acquired pneumonia among Vietnamese adults: a prospective surveillance in Central Vietnam. BMC Infect Dis 2013; 13: 296.
11. Wiemken T, Peyrani P, Bryant K, et al. Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project. Eur JClin Microbiol Infect Dis 2013; 32: 705-710.
12. Musher DM, Roig IL, Cazares G, et al. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 2013; 67: 11-18.
13. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573-577.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
15. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health 2014; 72: 39.
16. Harris RJ, Bradburn MJ, Deeks JJ, et al. Metan: fixed- and random-effects meta-analysis. Stata J2008; 8: 3-28.
17. Charles PG, Whitby M, Fuller AJ, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008; 46: 1513-1521.
18. Cilloniz C, Ewig S, Ferrer M, et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care 2011; 15: R209.
19. Das D, Le Floch H, Houhou N, et al. Viruses detected by systematic multiplex polymerase chain reaction in adults with suspected community-acquired pneumonia attending emergency departments in France. Clin Microbiol Infect 2015; 21: 608.e1-608.e8.
20. Diederen BM, Van Der Eerden MM, Vlaspolder F, et al. Detection of respiratory viruses and Legionella spp. by real-time polymerase chain reaction in patients with community acquired pneumonia. Scand J Infect Dis 2009; 41: 45-50.
21. Hohenthal U, Vainionpaa R, Meurman O, et al. Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity. Scand J Infect Dis 2008; 40: 131-138.
22. Holm A, Nexoe J, Bistrup LA, et al. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br J Gen Pract 2007; 57: 547-554.
23. Holter JC, Muller F, Bjorang O, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis 2015; 15: 64.
24. Huijskens EG, Koopmans M, Palmen FM, et al. The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia. J Med Microbiol 2014; 63: 441-452.
25. Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. NEngl J Med 2015; 373: 415-427.
26. Johansson N, Kalin M, Tiveljung-Lindell A, et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010; 50: 202-209.
27. Johnstone J, Majumdar SR, Fox JD, et al. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest 2008; 134: 1141-1148.
28. Karhu J, Ala-Kokko TI, Vuorinen T, et al. Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis 2014; 59: 62-70.
29. Kim JE, Kim UJ, Kim HK, et al. Predictors of viral pneumonia in patients with community-acquired pneumonia. PLoS One 2014; 9: e114710.
30. Lieberman D, Shimoni A, Shemer-Avni Y, et al. Respiratory viruses in adults with community-acquired pneumonia. Chest 2010; 138: 811-816.
31. Qu JX, Gu L, Pu ZH, et al. Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity. BMC Infect Dis 2015; 15: 89.
32. Saito A, Kohno S, Matsushima T, et al. Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother 2006; 12: 63-69.
33. Sangil A, Calbo E, Robles A, et al. Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses. Eur J Clin Microbiol Infect Dis 2012; 31: 2765-2772.
34. Shibli F, Chazan B, Nitzan O, et al. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J 2010; 12: 477-482.
35. Viasus D, Marinescu C, Villoslada A, et al. Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study. J Infect 2013; 67: 185-193.
36. Yin YD, Zhao F, Ren LL, et al. Evaluation of the Japanese Respiratory Society guidelines for the identification of Mycoplasma pneumoniae pneumonia. Respirology 2012; 17: 1131-1136.
37. Hayden FG. Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir Viruses 2013; 7: Suppl. 3, 36-43.
38. Kim SJ, Kim K, Park SB, et al. Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia. PLoS One 2015; 10: e0122642.
39. Li BJ, Tang Q, Cheng D, et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 2005; 11: 944-951.
40. Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013; 495: 251-254.
41. Alvarez R, Elbashir S, Borland T, et al. RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 2009; 53: 3952-3962.
42. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167: 775-785.
43. Kumar S, Wang L, Fan J, et al. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol 2008; 46: 3063-3072.
44. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198: 962-970.
45. van der Sluijs KF, van der Poll T, Lutter R, et al. Bench-to-bedside review: bacterial pneumonia with influenza -pathogenesis and clinical implications. Crit Care 2010; 14: 219.
46. Grabowska K, Hogberg L, Penttinen P, et al. Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infect Dis 2006; 6: 58.
47. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302: 1896-1902.
48. Wang M, Cai F, Wu X, et al. Incidence of viral infection detected by PCR and real-time PCR in childhood community-acquired pneumonia: a meta-analysis. Respirology 2015; 20: 405-412.
49. Wu X, Wang Q, Wang M, et al. Incidence of respiratory viral infections detected by PCR and real-time PCR in adult patients with community-acquired pneumonia: a meta-analysis. Respiration 2015; 89: 343-352.
50. Jartti T, Lehtinen P, Vuorinen T, et al. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 2004; 72: 695-699.